Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
It is very uncertain whether dopamine agonist changes incidence of moderate or severe OHSS compared with other active intervention (very low certainty).
Dopamine agonist showed no clear difference in live birth rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in clinical pregnancy rate compared with other active intervention (moderate certainty).
Dopamine agonist showed no clear difference in multiple pregnancy rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in miscarriage rate compared with other active intervention (low certainty).
Dopamine agonist showed no clear difference in live birth rate compared with placebo/no intervention (low certainty).
Dopamine agonist showed no clear difference in clinical pregnancy rate compared with placebo/no intervention (low certainty).
It is very uncertain whether dopamine agonist changes multiple pregnancy rate compared with placebo/no intervention (very low certainty).
Dopamine agonist showed no clear difference in miscarriage rate compared with placebo/no intervention (low certainty).
It is very uncertain whether dopamine agonist changes any other adverse events compared with placebo/no intervention (very low certainty).
Dopamine agonist plus co‐intervention may leads to lower incidence of moderate or severe OHSS compared with co‐intervention (low certainty).
Dopamine agonist plus co‐intervention showed no clear difference in live birth rate compared with co‐intervention (low certainty).
Dopamine agonist plus co‐intervention showed no clear difference in clinical pregnancy rate compared with co‐intervention (low certainty).
Coenzyme Q10 probably leads to lower all‐cause mortality compared with placebo or conventional therapy (moderate certainty).
Coenzyme Q10 showed no clear difference in myocardial infarction compared with placebo or conventional therapy (low certainty).
Coenzyme Q10 showed no clear difference in stroke compared with placebo or conventional therapy (low certainty).
Coenzyme Q10 probably leads to lower hospitalisation for heart failure compared with placebo or conventional therapy (moderate certainty).